Sanofi Matches, But Does Not Better, Amgen In OX40 Contest
Mid-stage data on amlitelimab in uncontrolled atopic dermatitis look in line with rival rocatinlimab, which is already more advanced.
Mid-stage data on amlitelimab in uncontrolled atopic dermatitis look in line with rival rocatinlimab, which is already more advanced.